AGL - AGL Investors: Investors with Significant Losses Should Contact Robbins LLP About the agilon health inc. Class Action | Benzinga
SAN DIEGO, April 09, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of (a) all persons and entities that purchased or otherwise acquired agilon health, inc. (NYSE:AGL) common stock between January 9, 2023 and January 4, 2024, and (b) all persons and entities that purchased or otherwise acquired agilon health, inc. common stock in connection with the Company's May 2023 secondary public offering ("SPO"). Agilon generates profits from reducing medical expenditures.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: Robbins LLP is Investigating the Allegations that agilon health, inc. (AGL) Misled Investors Regarding Medical Costs
According to the complaint, during the class period and in the SPO materials, defendants misled investors about agilon's medical costs by: (1) touting the Company's purported visibility into utilization trends and medical costs; ...